Ticker Details
Medpace Holdings, Inc. Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.
IPO Date:	August 11, 2016
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$12.88B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.82 | 1.63%
Avg Daily Range (30 D):	$10.25 | 1.97%
Avg Daily Range (90 D):	$7.84 | 1.43%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.32M
Avg Daily Volume (90 D):	.24M

Trade Size
Avg Trade Size (Sh.):	44
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	20

Institutional Trades
Total Institutional Trades:	3,156
Avg Institutional Trade:	$6.58M
Avg Institutional Trade (30 D):	$21.42M
Avg Institutional Trade (90 D):	$19.25M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$7.97M
Avg Closing Trade (30 D):	$23.55M
Avg Closing Trade (90 D):	$22.75M
Avg Closing Volume:	41K

News

Feb 16, 2026 @ 6:30 PM Why Big Stock Swings Like Medpace's 55% Jump Usual... Source: Motley Fool Youtube

Feb 15, 2026 @ 1:32 PM Pinterest, DraftKings, And Flutter Are Among Top 1... Source: Nabaparna Bhattacharya

Nov 28, 2025 @ 2:00 PM Innovative Drug CRO Market to Soar USD 96.06 Billi... Source: Towards Healthcare

Oct 24, 2025 @ 5:05 PM Why Medpace Popped 13% This Week Source: Brett Schafer

Oct 23, 2025 @ 4:00 PM Medpace's Q3 Earnings Beat Reflects Robust Growth ... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$15.64	$4.76	$15.64
Diluted EPS	$15.28	$4.64	$15.28
Revenue	$2.53B	$708.45M	$2.53B
Gross Profit	$760.62M	$205.32M	$760.62M
Net Income / Loss	$451.12M	$135.13M	$451.12M
Operating Income / Loss	$534.94M	$153.27M	$534.94M
Cost of Revenue	$1.77B	$503.13M	$1.77B
Net Cash Flow	$-172.39M	$211.7M	$-172.39M
PE Ratio	28.44